AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
190.55
+3.44 (1.84%)
At close: Jul 23, 2025, 4:00 PM
190.55
0.00 (0.00%)
After-hours: Jul 23, 2025, 6:33 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
The 22 analysts that cover AbbVie stock have a consensus rating of "Buy" and an average price target of $213.14, which forecasts a 11.86% increase in the stock price over the next year. The lowest target is $190 and the highest is $250.
Price Target: $213.14 (+11.86%)
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2025.
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 7 | 6 |
| Buy | 10 | 10 | 11 | 11 | 11 | 11 |
| Hold | 3 | 3 | 4 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 23 | 23 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $210 → $205 | Strong Buy → Hold | Downgrades | $210 → $205 | +7.58% | May 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $214 → $216 | Strong Buy | Maintains | $214 → $216 | +13.36% | Apr 29, 2025 |
| Raymond James | Raymond James | Buy Maintains $220 → $227 | Buy | Maintains | $220 → $227 | +19.13% | Apr 28, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $204 → $205 | Buy | Maintains | $204 → $205 | +7.58% | Apr 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $241 → $250 | Buy | Maintains | $241 → $250 | +31.20% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
61.11B
from 56.33B
Increased by 8.47%
Revenue Next Year
66.13B
from 61.11B
Increased by 8.22%
EPS This Year
12.39
from 2.39
Increased by 418.32%
EPS Next Year
14.29
from 12.39
Increased by 15.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 63.9B | 70.5B | 75.7B | ||
| Avg | 61.1B | 66.1B | 70.7B | ||
| Low | 58.1B | 61.0B | 65.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.4% | 15.4% | 14.4% | ||
| Avg | 8.5% | 8.2% | 7.0% | ||
| Low | 3.1% | -0.2% | -0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.34 | 15.83 | 18.01 | ||
| Avg | 12.39 | 14.29 | 15.82 | ||
| Low | 11.56 | 12.68 | 13.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 457.9% | 27.8% | 26.0% | ||
| Avg | 418.3% | 15.3% | 10.8% | ||
| Low | 383.8% | 2.4% | -2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.